AI-Guided fluid drips may cut surgery risks in large trial
NCT ID NCT06011187
First seen Sep 30, 2025 · Last updated Jun 17, 2026 · Updated 31 times
Summary
This study tested an artificial intelligence system that helps doctors decide when to give fluids during high-risk abdominal surgery. The goal was to see if using this smart system could reduce serious complications like kidney injury, infections, or heart problems within 30 days after surgery. About 2007 high-risk adults took part in the study across multiple hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECISION SUPPORT SYSTEM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ALEXANDRE JOOSTEN, MD PhD
Le Kremlin-Bicêtre, France, 94200, France
-
BEAUJON
Paris, Paris, France
-
BICETRE
Le Kremlin-Bicêtre, Paris, France
-
CHUM Montreal
Montreal, Montreal, Canada
-
Centre chirurgical Marie Lannelongue
Le Plessis-Robinson, Haut de Seine, France
-
Centre hospitalier universitaire de NANCY
Nancy, France
-
Chu Dijon
Dijon, Dijon, France
-
Chu Grenoble Alpes
Grenoble, Grenoble, France
-
Chu Lille
Lille, France
-
Chu Toulouse
Toulouse, Toulouse, France
-
HEGP
Paris, PARIS, France
-
Insititut Mutualiste Montsouris
Paris, Paris, France
-
La Pitie Salpetriere
Paris, PARIS, France
-
UZ Brussels
Brussels, Brussels Capital, Belgium
-
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany
-
University of California IRVINE
Irvine, California, 92868, United States
-
University of California Los Angeles (UCLA)
Los Angeles, California, 90095, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.